Affiliation:
1. Department of Environmental Science, Baylor University, Waco, TX 76798, USA
Abstract
Parkinson’s disease (PD) is a neurodegenerative condition marked by loss of motor coordination and cognitive impairment. According to global estimates, the worldwide prevalence of PD will likely exceed 12 million cases by 2040. PD is primarily associated with genetic factors, while clinically, cases are attributed to idiopathic factors such as environmental or occupational exposure. The heavy metals linked to PD and other neurodegenerative disorders include copper, manganese, and zinc. Chronic exposure to metals induces elevated oxidative stress and disrupts homeostasis, resulting in neuronal death. These metals are suggested to induce idiopathic PD in the literature. This study measures the effects of lethal concentration at 10% cell death (LC10) and lethal concentration at 50% cell death (LC50) concentrations of copper, manganese, and zinc chlorides on SH-SY5Y cells via markers for dopamine, reactive oxygen species (ROS) generation, DNA damage, and mitochondrial dysfunction after a 24 h exposure. These measurements were compared to a known neurotoxin to induce PD, 100 µM 6-hydroxydopamine (6-ODHA). Between the three metal chlorides, zinc was statistically different in all parameters from all other treatments and induced significant dopaminergic loss, DNA damage, and mitochondrial dysfunction. The LC50 of manganese and copper had the most similar response to 6-ODHA in all parameters, while LC10 of manganese and copper responded most like untreated cells. This study suggests that these metal chlorides respond differently from 6-ODHA and each other, suggesting that idiopathic PD utilizes a different mechanism from the classic PD model.
Funder
Henry F. Jackson Foundation
C. Gus Glasscock, Jr. Endowed Fund for Excellence in Environmental Sciences
Department of Environmental Science at Baylor University
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference67 articles.
1. Nakmode, D.D., Day, C.M., Song, Y., and Garg, S. (2023). The Management of Parkinson’s Disease: An Overview of the Current Advancements in Drug Delivery Systems. Pharmaceutics, 15.
2. The emerging evidence of the Parkinson Pandemic;Dorsey;J. Park. Dis.,2018
3. Parkinson’s disease;Bloem;Lancet,2021
4. Parkinson’s disease and the environment;Ball;Front. Neurol.,2019
5. Occupational factors and risk of Parkinson’s disease: A population-based case–control study;Firestone;Am. J. Ind. Med.,2010